We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Marina Biotech Announces Worldwide Exclusive Licensing Agreement With Monsanto

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Marina Biotech Announces Worldwide Exclusive Licensing Agreement With Monsanto"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Marina Biotech, Inc. has announced that it has entered into an exclusive licensing agreement with Monsanto Company for Marina Biotech's delivery and chemistry technologies. Terms of the agreement were not disclosed.

"We are pleased to enter into this agreement with Monsanto, a global leader in agriculture and crop sciences," stated J. Michael French, President and Chief Executive Officer of Marina Biotech.

French continued, "Over the last several years, we have been focused on bringing together novel chemistry and delivery technologies necessary to broadly apply our discovery platform across the life sciences sector. We view this license as yet another important validation of this platform and we look forward to a strong and growing relationship with Monsanto."